SlideShare a Scribd company logo
1 of 23
Nursing Interventions for Improved
Oral Chemotherapy Adherence
Alicia Vautour
Susan D. Flynn Oncology Fellow
August 27, 2015
Objectives
• Background on Oral Chemotherapy
• Describe the Problem
• Present Nursing Interventions for
Standardizing Oral Chemotherapy: Research
• Describe Oral Chemo Resources at DFCI
• Provide Recommendations for Improvement
2
Background
• Chemotherapy
– Infusion vs Pills
• What is Oral Chemotherapy?
– Cancer-fighting drug
– PO tablet, capsule, liquid form
• Why Oral Chemotherapy?
– Taken at home
• Can Improve Quality of Life
– Less frequent visits to hospital/clinic
Dana-Farber.org
3
Safety of Oral Chemo
• Education
– How to take the drug
– Storage
– Disposal
– Safe Handling of body waste
– Laundry
– Side Effects
– When to call/come in to Hospital
Dana-Farber.org
4
Why This Topic
• Witnessed Pt in clinic with multiple bottles of
chemo pills that were full
• Preliminary Research
– Non-Adherence: Pt Barriers
– National problem with pt adherence
• ASCO initiated project to develop standards for safe chemo
administration
– Many trials underway to standardize the education
– prescribing of oral chemo and  production of new
oral chemo
5
Barriers to Adherence
• Socioeconomic
• Healthcare System
• Disease
• Treatment Regimen
• Patient Related
University of Pennsylvania Medicine, 2015
9/14/2015 6
Barriers: Managing Side Effects
• Common Side Effects of Oral Chemotherapy
– Varies from drug to drug
– Targeted Therapies
• Skin
– Acne-Like Rash (face, neck, chest, back)
– Dry Skin
– Itching
• Hair
– Alopecia/thinning
– Growing (i.e. face)
• Nail
– Painful swelling & redness
– Infected nailbeds (require antibiotics)
• Follow up with pts to manage and treat side effects
MASCC
9/14/2015 7
MASCC Education
9/14/2015 8
Research- National Survey
• Objective:
– Describe current nursing practice in US regarding care and safety of pts
taking oral chemo
– Study
• National Online Survey
– Emailed to 5000 members of Oncology Nursing Society
• 577 oncology nurses in outpatient settings
• Variables: pt care practices, nursing resources, and barriers to medication
adherence
• Results:
– 51% worked in practices that had developed specific policies,
procedures and resources for pts on oral chemo
– Barriers: Cost (81%) and Side Effects (72%)
Roop & Wu 2014
9
Research-Loma Linda University
• Objective:
– Improved outcomes in adherence by an oral chemotherapy management clinic
– Study
• Loma Linda University Cancer Center
• Retrospective Cohort Study: 30 pts evaluated
• Oncology pharmacists developed a comprehensive oral chemotherapy management
clinic (face-to-face initial and 3 month visits w/ RN, MD, & Pharmacists, telephone follow-
ups at 3-5 days and 7-10 days, and unscheduled visits prn)
• Results:
– Prevented moderate to severe drug interaction
– Improved symptom management
– Decreased cost of patient care
– No missed doses for 21 of the 30 pts
Wong, Bounthavong, Nguyen, Bechtoldt, & Hernandez, 2014
10
Research-Literature Review
• Objective:
– Describe the development of an oral chemotherapy nursing position
– Improve medication safety and adherence
– Article
• 112 pts at one time
• Initial teaching to 163 pts
• Nursing assessments and interventions provided for 1,710 pts before
their next cycle of chemo
• Telephone Triage to 2,410 pt calls
• Results:
– In the 2 yrs following the program, 3 of 1710 pts were known to have
varied from their prescribed regimens
– Oral chemotherapy nurse obtained excellent adherence outcomes
Moody & Jackowski, 2014
9/14/2015 11
Donna Berry, Phd, RN
• https://www.youtube.com/watch?v=OSUp6xT
ksLg
9/14/2015 12
DFCI Study
• Objective:
– Evaluate a nurse-led intervention to enhance medication knowledge &
adherence using MOATT
– Study
• 30 adult pts with lung cancer receiving oral Erlotinib at DFCI
• Nurse-led education sessions using MOATT, 72- hour follow-up telephone contact, pts
completed KRS and MMAS-8
• Variables: knowledge & adherence; feasibility
• Results:
– 27 pts completed study reporting high knowledge levels and MMAS-8 scores
– Pts also initiated contact for assistance with prescription procurement &
symptom management
– Feasible
– Adherence & knowledge outcomes were encouraging
Boucher, Lucca, Hooper, Pedulla, & Berry, 2015
9/14/2015 13
MOATT
9/14/2015 14
© 2008 Multinational Association of Supportive Care in Cancer
TM
MASCC TEACHING TOOL FOR PATIENTS
RECEIVING ORAL AGENTS FOR CANCER
(MOATT)©
This teaching tool has been prepared to
assist health care providers in the
assessment and education of patients
receiving oral agents as treatment for their
cancer. The goal is to ensure that patients
know and understand their treatment and the
importance of taking the pills/tablets that are
prescribed.
The following are aspects that impact the
adherence to treatment with oral agents
(pills/tablets) for cancer
Patient Characteristics
Drug
Disease
Treatment Plan
Include family member or other healthcare provider
in this information.
KEY ASSESSMENT QUESTIONS
1) What have you been told about this treatment
plan with oral medications?
* Verify that the patient knows that these oral
agents are for cancer and are taken by mouth for
their cancer.
2) What other medications or pills do you take by
mouth?
* If you have a list of medicines, go over the list with
the patient.
* If you do not have a list, ask the patient what
medicines he/she is taking, (both prescription and
non-prescription), herbs, complementary, or other
treatments.
3) Are you able to swallow pills or tablets? If no,
explain.
4) Are you able to read the drug label/information?
5) Are you able to open your other medicine
bottles or packages?
6) Have you taken other pills for your cancer?
* Find out if there were any problems, for example,
taking the medications or any adverse drug effects.
7) Are you experiencing any symptoms that would
affect your ability to keep down the pills, for
example nausea or vomiting?
8) How will you fill your prescription?
* Delays in obtaining the pills may affect when the
oral drugs are started
9) Have you had any problems with your
insurance that has interfered with obtaining your
medications?
Special Considerations when assessing
patients receiving oral agents for cancer:
When teaching the patient, you may need to
adapt your teaching to accommodate special
considerations such as, age, feeding tube, vision
problems/color blindness, dietary issues, mental
problems (dementia, depression, cognitive
impairments).
* Recommended information to assess is noted in italics
PATIENT EDUCATION
Generic Education for All Oral Drugs
Discuss the following items with the patient
and/or caretaker.
1) Inform any other doctors, dentists or healthcare
providers that you are taking pills/tablets for your
cancer.
2) Keep the pills/tablets away from children and pets
and in a childproof container.
3) Keep the pills/tablets in the original container,
unless otherwise directed. It could be dangerous
to mix with other pills.
4) Wash your hands before and after handling the
pills/tablets.
5) Do not crush, chew, cut or disrupt your
pills/tablets unless directed otherwise
6) Store your pills/tablets away from heat, sunlight,
or moisture as it may degrade the pills/tablets,
potentially making them less effective.
7) Have a system to make sure you take your
pills/tablets correctly.
* Give the patient some ideas, such as timer, clock or
calendar.
8) Make sure you have directions about what to do if
you miss a dose
9) If you accidentally take too many pills or if
someone else takes your pills/tablets, contact
your Doctor or nurse immediately.
10) Ask your nurse or pharmacist what you should do
with any pills/tablets you have not taken or are
out-dated.
* The patient may be asked to bring unused
pills/tablets back to the next visit.
11) Carry with you a list of medicines that you are
taking, including your cancer pills/tablets.
12) Let us know if you have a problem with paying for
or getting your pills.
13) Plan ahead for travel, refills and weekends.
MOATT
© 2008 Multinational Association of Supportive Care in Cancer
TM
DRUG-SPECIFIC INFORMATION
Drug name (generic and trade)
__________________________________________
What the drug looks like
__________________________________________
Dose and schedule
How many different pills?
__________________________________
How many times a day?
___________________________________
For how long?
__________________________________________
Where the drug should be stored
* Be specific, for example, away from heat (not in the
kitchen), humidity (not in the bathroom), sun (not on the
window sill)
__________________________________________
__________________________________________
What are potential side effects and management of
them?
* Include lab evaluations or any medical tests that will
be used for drug monitoring.
__________________________________________
__________________________________________
__________________________________________
__________________________________________
Are there any precautions?
__________________________________________
__________________________________________
__________________________________________
Are there any drug and food interactions?
__________________________________________
__________________________________________
When and whom to call with questions
* Give names and phone numbers here
__________________________________________
__________________________________________
EVALUATE
Have the patient and/or caregiver answer
the following questions to ensure that
they understand what information you
have given them.
You have received a lot of information today.
Let’s review key points.
What is/are the name(s) of your cancer
pill(s)/tablet(s)?
When will you take your cancer pill(s)/tablet(s)?
Does it matter if you take this pill/tablet with food
or not?
Where do you plan to keep it?
When should you call the Doctor or Nurse?
Do you have any other questions?
Your next appointment is?
______________________________________
For problems, contact
______________________________________
______________________________________
______________________________________
______________________________________
______________________________________
Drug-Specific Education –
The following information relates to topics and
references for the specific treatment that the
patient is receiving.
Refer to drug specific information to educate the patient on
his/her pills/tablets
References
Product package insert or prescribing
information
http://www.cancerbackup.org.uk/Treatments/Ch
emotherapy/Individualdrugs
Micromedix
AHFS Drug Info.
http://www.cancersource.com/LibraryAndResou
rces/DrugGuide/
http://www.naturaldatabase.com
Add website addresses, email links, internet sites
Whichever tool is used to educate the patient,
include the following drug-specific information. You
can complete the form provided below and give it to
the patients using reference material you have on
the specific pills/tablets.
Drug name (generic and trade)
What the drug looks like
Dose and schedule.
How many different pills?
How many times a day?
For how long?
Where to store the drug
* Be specific, for example, away from heat (not in the
kitchen), humidity (not in the bathroom), sun (not on
the window sill)
What are potential side effects and management of
them?
* Include lab evaluations or any medical tests that will
be used for drug monitoring.
Are there any precautions?
Are there any drug and food interactions?
When and whom to call with questions
* Give names and phone numbers here
9/14/2015 15
Drug Diary
One Oral Chemotherapy Once a Day
DRUG NAME:
Start Date:___________
How
much:_________
How often:___________ When:___________
Your MD: ____________ Phone:____________
Your RN: ____________ Phone:____________
Special Instructions:
Day Date Time Dose Symptoms
Example 1/2/2011 9:30 AM 1 tablet upset stomach hour later
1 : AM/PM
2 : AM/PM
3 : AM/PM
4 : AM/PM
5 : AM/PM
9/14/2015 16
Oral Chemo Videos
• https://www.youtube.com/watch?v=vzVDafn3
iHA
– 4-part, web based oral chemo animated video
series
– Available in English, Spanish, Portuguese,
Mandarin, Russian, and Arabic
9/14/2015 17
Conversation with Kitty Hooper
• What is going on at DFCI now?
– Initial phone call
• MOATT
• Pharmacy directed
• Calls documented in EPIC
– 72 hour adherence phone call
• Program nurse
• Go over side effects
• Avg call 10-15 mins
– 2 week follow-up visit with provider
• 2 week peak drug toxicity
• Review drug diaries
– Every 2 months
• May 2015: 80% of oral chemo pts had teaching
Kitty Hooper, personal communication, August 11, 2015
9/14/2015 18
Ongoing Issues at DFCI
• Phone call based
– No in person teaching
• Initial education no longer done by nursing
• Difficult to see if a patient is on oral
chemotherapy
• Lack of nursing knowledge
• Inconsistencies in Research Nursing
Kitty Hooper, August 2015
9/14/2015 19
Suggestions for Improvement
• Bring the education back to the nurses
– Program nurse in each disease center
– Oral Chemo Nurse position
• Continue standardized documentation forms for telephone calls
that include administration instructions, precautions, monitoring
and managing SE, etc
– Standardize Research oral chemo as well
• Scheduling pt for 2 education appts w/RN prior to prescribing oral
chemo
• RN maintaining weekly call list for each patient on oral chemo
• Routine follow-up phone calls or one week follow-up office visits
• Improve view of oral chemo within EPIC
• Providing classes for nurses & adding oral chemo as an annual
competency (? Healthstream)
9/14/2015 20
Questions?
9/14/2015 21
References
Boucher, J., Lucca, J., Hooper, D., Pedulla, L., & Berry, D. (2015). A structured nursing intervention to address oral
chemotherapy adherence in patients with non-small cell lung cancer. Oncology Nursing Forum, 42(4),
383-389. doi: 10.1188/15.ONF.383-389
Dana Farber Cancer Institute. (2015). Chemotherapy. Retrieved from http://www.dana-farber.org/Adult-
Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Chemotherapy.aspx
Moody, M., & Jackowski, J. (2014). Are patients on oral chemotherapy in your practice setting safe? Clinical Journal of
Oncology Nursing, 14, 339–346. doi:10.1188/10.CJON.339-346
Nuess, M., Polovich, M., McNiff, K., Esper, P., Gilmore, T., LeFebvre, K., Schulmeister, L., & Jacobson, J. (2013).
2013 updated american society of clinical oncology/oncology nursing society chemotherapy administration
safety standards including standards for the safe administration and management of oral chemotherapy.
Oncology Nursing Forum, 40(3), 225-233. doi:10.1188/13.ONF.40-03AP2
Penn Medicine. (2013). Patient adherence to oral cancer therapies: A nursing resource guide. OncoLink, 1-8.
Retrieved from www.oncolink.org
Rittenberg, C., Johnson, J., Kav, S., Barber, L., & Lemonde, M. (2010). MASCC oral agent teaching tool (MOATT).
MASCC, 1-28.
Roop, Janna & Wi, Horng-Shiuann. (2014). Current practice patterns for oral chemotherapy: Results of a national
survey. Oncology Nursing Forum, 41(2), 185-194. doi:10.1188/14.ONF.41-02AP
Wong, S., Bounthavong, M., Nguyen, C., Bechtoldt, K., & Hernandez, E. (2014). Implementation and preliminary
outcomes of a comprehensive oral chemotherapy management clinic. American Journal of Health-System
Pharmacy, 71(11) 960-965. doi: 10.2146/ajhp130278
9/14/2015 22
9/14/2015 23
DFCI, BWH, & Fred Flynn

More Related Content

What's hot

Detection and monitoring of ADRs
Detection and monitoring of ADRsDetection and monitoring of ADRs
Detection and monitoring of ADRsDr. Ramesh Bhandari
 
8. pharmacotherapy
8. pharmacotherapy8. pharmacotherapy
8. pharmacotherapyGerika Aura
 
Concept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugsConcept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugsNilayan Guha
 
Pharmaceutical Care of Patients with Infections | 29/03/2010
Pharmaceutical Care of Patients with Infections | 29/03/2010Pharmaceutical Care of Patients with Infections | 29/03/2010
Pharmaceutical Care of Patients with Infections | 29/03/2010NES
 
Adr; pharmacovigilance & Drug Interactions
Adr; pharmacovigilance & Drug InteractionsAdr; pharmacovigilance & Drug Interactions
Adr; pharmacovigilance & Drug InteractionsDr Manish Pal Singh
 
Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)elsanimadhan
 
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2maykamen
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist ReportingRishi Kumar
 
Essential medicine concepts
Essential medicine conceptsEssential medicine concepts
Essential medicine conceptsViraj Shinde
 
MHRA Yellow Card Scheme
MHRA Yellow Card SchemeMHRA Yellow Card Scheme
MHRA Yellow Card SchemeThe QCCP
 
How to fill adr reporitng form
How to fill adr reporitng formHow to fill adr reporitng form
How to fill adr reporitng formkopalsharma85
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse eventsKatla Swapna
 
Introduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceIntroduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceAimen Salman
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy ShaistaSumayya
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentationLisa Tripp
 

What's hot (20)

Pharmacovigilance in pediatrics
Pharmacovigilance in pediatricsPharmacovigilance in pediatrics
Pharmacovigilance in pediatrics
 
Detection and monitoring of ADRs
Detection and monitoring of ADRsDetection and monitoring of ADRs
Detection and monitoring of ADRs
 
Special populations
Special populationsSpecial populations
Special populations
 
8. pharmacotherapy
8. pharmacotherapy8. pharmacotherapy
8. pharmacotherapy
 
Clinicalpharmacy 2
Clinicalpharmacy 2Clinicalpharmacy 2
Clinicalpharmacy 2
 
Concept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugsConcept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugs
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Pharmaceutical Care of Patients with Infections | 29/03/2010
Pharmaceutical Care of Patients with Infections | 29/03/2010Pharmaceutical Care of Patients with Infections | 29/03/2010
Pharmaceutical Care of Patients with Infections | 29/03/2010
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adr; pharmacovigilance & Drug Interactions
Adr; pharmacovigilance & Drug InteractionsAdr; pharmacovigilance & Drug Interactions
Adr; pharmacovigilance & Drug Interactions
 
Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)Therapeutic Drug Monitoring (TDM)
Therapeutic Drug Monitoring (TDM)
 
Polypharmacy full guidance v2
Polypharmacy full guidance v2Polypharmacy full guidance v2
Polypharmacy full guidance v2
 
ADR Pharmacist Reporting
ADR Pharmacist ReportingADR Pharmacist Reporting
ADR Pharmacist Reporting
 
Essential medicine concepts
Essential medicine conceptsEssential medicine concepts
Essential medicine concepts
 
MHRA Yellow Card Scheme
MHRA Yellow Card SchemeMHRA Yellow Card Scheme
MHRA Yellow Card Scheme
 
How to fill adr reporitng form
How to fill adr reporitng formHow to fill adr reporitng form
How to fill adr reporitng form
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse events
 
Introduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceIntroduction to clinical pharmacy practice
Introduction to clinical pharmacy practice
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentation
 

Viewers also liked

Chemo In a Bottle: Oral Chemotherapy for Colorectal Cancer
Chemo In a Bottle: Oral Chemotherapy for Colorectal CancerChemo In a Bottle: Oral Chemotherapy for Colorectal Cancer
Chemo In a Bottle: Oral Chemotherapy for Colorectal CancerFight Colorectal Cancer
 
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...HMO Research Network
 
Cco Gi 2008 Cr Slideset
Cco Gi 2008 Cr SlidesetCco Gi 2008 Cr Slideset
Cco Gi 2008 Cr SlidesetEmad El-Nashar
 
Building electronic chemotherapy order by RabbitChemo
Building electronic chemotherapy order by RabbitChemoBuilding electronic chemotherapy order by RabbitChemo
Building electronic chemotherapy order by RabbitChemorabbitchemo
 
Simulation for Chemotherapy Administration Training with Standardized Patients
Simulation for Chemotherapy Administration Training with Standardized PatientsSimulation for Chemotherapy Administration Training with Standardized Patients
Simulation for Chemotherapy Administration Training with Standardized PatientsMelissa Jo Powell
 
What Next? Answering the question of life after chemotherapy at Memorial Sloa...
What Next? Answering the question of life after chemotherapy at Memorial Sloa...What Next? Answering the question of life after chemotherapy at Memorial Sloa...
What Next? Answering the question of life after chemotherapy at Memorial Sloa...Joseph Gray
 
Lec # 4 oncology ccn
Lec # 4 oncology ccnLec # 4 oncology ccn
Lec # 4 oncology ccnAli Sheikh
 
Chemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical StudentsChemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical StudentsProf. Shad Salim Akhtar
 
3. Transitioning to home setting
3. Transitioning to home setting3. Transitioning to home setting
3. Transitioning to home settingChartwellPA
 
Chemotherapy safety and handling-Thao's presentation
Chemotherapy safety and handling-Thao's presentationChemotherapy safety and handling-Thao's presentation
Chemotherapy safety and handling-Thao's presentationHA VO THI
 
Faye Glenn A
Faye Glenn AFaye Glenn A
Faye Glenn Anva226
 
Chemotherapy treatment education
Chemotherapy treatment educationChemotherapy treatment education
Chemotherapy treatment educationJane Webley
 

Viewers also liked (17)

Chemo In a Bottle: Oral Chemotherapy for Colorectal Cancer
Chemo In a Bottle: Oral Chemotherapy for Colorectal CancerChemo In a Bottle: Oral Chemotherapy for Colorectal Cancer
Chemo In a Bottle: Oral Chemotherapy for Colorectal Cancer
 
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...
Adherence to Surveillance Care Guidelines After Breast and Colorectal Cancer ...
 
04 gustafsson
04 gustafsson04 gustafsson
04 gustafsson
 
Resume 10.2015
Resume 10.2015Resume 10.2015
Resume 10.2015
 
Cco Gi 2008 Cr Slideset
Cco Gi 2008 Cr SlidesetCco Gi 2008 Cr Slideset
Cco Gi 2008 Cr Slideset
 
Crisis
CrisisCrisis
Crisis
 
Building electronic chemotherapy order by RabbitChemo
Building electronic chemotherapy order by RabbitChemoBuilding electronic chemotherapy order by RabbitChemo
Building electronic chemotherapy order by RabbitChemo
 
Simulation for Chemotherapy Administration Training with Standardized Patients
Simulation for Chemotherapy Administration Training with Standardized PatientsSimulation for Chemotherapy Administration Training with Standardized Patients
Simulation for Chemotherapy Administration Training with Standardized Patients
 
What Next? Answering the question of life after chemotherapy at Memorial Sloa...
What Next? Answering the question of life after chemotherapy at Memorial Sloa...What Next? Answering the question of life after chemotherapy at Memorial Sloa...
What Next? Answering the question of life after chemotherapy at Memorial Sloa...
 
Lec # 4 oncology ccn
Lec # 4 oncology ccnLec # 4 oncology ccn
Lec # 4 oncology ccn
 
Chemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical StudentsChemotherapy for Nurses and Medical Students
Chemotherapy for Nurses and Medical Students
 
3. Transitioning to home setting
3. Transitioning to home setting3. Transitioning to home setting
3. Transitioning to home setting
 
Chemo1
Chemo1Chemo1
Chemo1
 
Chemotherapy safety and handling-Thao's presentation
Chemotherapy safety and handling-Thao's presentationChemotherapy safety and handling-Thao's presentation
Chemotherapy safety and handling-Thao's presentation
 
Faye Glenn A
Faye Glenn AFaye Glenn A
Faye Glenn A
 
Chemotheray nsg role
Chemotheray  nsg roleChemotheray  nsg role
Chemotheray nsg role
 
Chemotherapy treatment education
Chemotherapy treatment educationChemotherapy treatment education
Chemotherapy treatment education
 

Similar to Oral Chemotherapy Adherence

Workshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcaseWorkshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcaseaaltunalboro
 
Optimize Presentation
Optimize PresentationOptimize Presentation
Optimize Presentationaaltunalboro
 
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.varshawadnere
 
pharmacist patient education and counseling
pharmacist patient education and counseling pharmacist patient education and counseling
pharmacist patient education and counseling Hemat Elgohary
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxMansoorKhan22677
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
bretOral Chemo Poster 4.8.15
bretOral Chemo Poster 4.8.15bretOral Chemo Poster 4.8.15
bretOral Chemo Poster 4.8.15Taylor McEachon
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMLipanjali Badhei
 
Patient Education ppt
Patient Education pptPatient Education ppt
Patient Education pptAsad Khan
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Areej Abu Hanieh
 
The Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence SupportThe Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence Supporticapclinical
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdfUVAS
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptxAjithJs2
 
Medication Adherence.pdf
Medication Adherence.pdfMedication Adherence.pdf
Medication Adherence.pdfDr Ravikiran S
 

Similar to Oral Chemotherapy Adherence (20)

Workshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcaseWorkshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcase
 
Optimize Presentation
Optimize PresentationOptimize Presentation
Optimize Presentation
 
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
 
pharmacist patient education and counseling
pharmacist patient education and counseling pharmacist patient education and counseling
pharmacist patient education and counseling
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptx
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
 
medication adherence
medication adherencemedication adherence
medication adherence
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
bretOral Chemo Poster 4.8.15
bretOral Chemo Poster 4.8.15bretOral Chemo Poster 4.8.15
bretOral Chemo Poster 4.8.15
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
 
Clin Pharmacy
Clin PharmacyClin Pharmacy
Clin Pharmacy
 
Patient Education ppt
Patient Education pptPatient Education ppt
Patient Education ppt
 
Clinical pharmacy.pptx
Clinical pharmacy.pptxClinical pharmacy.pptx
Clinical pharmacy.pptx
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project
 
The Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence SupportThe Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence Support
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
 
research 1
research 1research 1
research 1
 
Medication Adherence.pdf
Medication Adherence.pdfMedication Adherence.pdf
Medication Adherence.pdf
 
Oral Chemo Journal Abstract
Oral Chemo Journal AbstractOral Chemo Journal Abstract
Oral Chemo Journal Abstract
 

Oral Chemotherapy Adherence

  • 1. Nursing Interventions for Improved Oral Chemotherapy Adherence Alicia Vautour Susan D. Flynn Oncology Fellow August 27, 2015
  • 2. Objectives • Background on Oral Chemotherapy • Describe the Problem • Present Nursing Interventions for Standardizing Oral Chemotherapy: Research • Describe Oral Chemo Resources at DFCI • Provide Recommendations for Improvement 2
  • 3. Background • Chemotherapy – Infusion vs Pills • What is Oral Chemotherapy? – Cancer-fighting drug – PO tablet, capsule, liquid form • Why Oral Chemotherapy? – Taken at home • Can Improve Quality of Life – Less frequent visits to hospital/clinic Dana-Farber.org 3
  • 4. Safety of Oral Chemo • Education – How to take the drug – Storage – Disposal – Safe Handling of body waste – Laundry – Side Effects – When to call/come in to Hospital Dana-Farber.org 4
  • 5. Why This Topic • Witnessed Pt in clinic with multiple bottles of chemo pills that were full • Preliminary Research – Non-Adherence: Pt Barriers – National problem with pt adherence • ASCO initiated project to develop standards for safe chemo administration – Many trials underway to standardize the education – prescribing of oral chemo and  production of new oral chemo 5
  • 6. Barriers to Adherence • Socioeconomic • Healthcare System • Disease • Treatment Regimen • Patient Related University of Pennsylvania Medicine, 2015 9/14/2015 6
  • 7. Barriers: Managing Side Effects • Common Side Effects of Oral Chemotherapy – Varies from drug to drug – Targeted Therapies • Skin – Acne-Like Rash (face, neck, chest, back) – Dry Skin – Itching • Hair – Alopecia/thinning – Growing (i.e. face) • Nail – Painful swelling & redness – Infected nailbeds (require antibiotics) • Follow up with pts to manage and treat side effects MASCC 9/14/2015 7
  • 9. Research- National Survey • Objective: – Describe current nursing practice in US regarding care and safety of pts taking oral chemo – Study • National Online Survey – Emailed to 5000 members of Oncology Nursing Society • 577 oncology nurses in outpatient settings • Variables: pt care practices, nursing resources, and barriers to medication adherence • Results: – 51% worked in practices that had developed specific policies, procedures and resources for pts on oral chemo – Barriers: Cost (81%) and Side Effects (72%) Roop & Wu 2014 9
  • 10. Research-Loma Linda University • Objective: – Improved outcomes in adherence by an oral chemotherapy management clinic – Study • Loma Linda University Cancer Center • Retrospective Cohort Study: 30 pts evaluated • Oncology pharmacists developed a comprehensive oral chemotherapy management clinic (face-to-face initial and 3 month visits w/ RN, MD, & Pharmacists, telephone follow- ups at 3-5 days and 7-10 days, and unscheduled visits prn) • Results: – Prevented moderate to severe drug interaction – Improved symptom management – Decreased cost of patient care – No missed doses for 21 of the 30 pts Wong, Bounthavong, Nguyen, Bechtoldt, & Hernandez, 2014 10
  • 11. Research-Literature Review • Objective: – Describe the development of an oral chemotherapy nursing position – Improve medication safety and adherence – Article • 112 pts at one time • Initial teaching to 163 pts • Nursing assessments and interventions provided for 1,710 pts before their next cycle of chemo • Telephone Triage to 2,410 pt calls • Results: – In the 2 yrs following the program, 3 of 1710 pts were known to have varied from their prescribed regimens – Oral chemotherapy nurse obtained excellent adherence outcomes Moody & Jackowski, 2014 9/14/2015 11
  • 12. Donna Berry, Phd, RN • https://www.youtube.com/watch?v=OSUp6xT ksLg 9/14/2015 12
  • 13. DFCI Study • Objective: – Evaluate a nurse-led intervention to enhance medication knowledge & adherence using MOATT – Study • 30 adult pts with lung cancer receiving oral Erlotinib at DFCI • Nurse-led education sessions using MOATT, 72- hour follow-up telephone contact, pts completed KRS and MMAS-8 • Variables: knowledge & adherence; feasibility • Results: – 27 pts completed study reporting high knowledge levels and MMAS-8 scores – Pts also initiated contact for assistance with prescription procurement & symptom management – Feasible – Adherence & knowledge outcomes were encouraging Boucher, Lucca, Hooper, Pedulla, & Berry, 2015 9/14/2015 13
  • 14. MOATT 9/14/2015 14 © 2008 Multinational Association of Supportive Care in Cancer TM MASCC TEACHING TOOL FOR PATIENTS RECEIVING ORAL AGENTS FOR CANCER (MOATT)© This teaching tool has been prepared to assist health care providers in the assessment and education of patients receiving oral agents as treatment for their cancer. The goal is to ensure that patients know and understand their treatment and the importance of taking the pills/tablets that are prescribed. The following are aspects that impact the adherence to treatment with oral agents (pills/tablets) for cancer Patient Characteristics Drug Disease Treatment Plan Include family member or other healthcare provider in this information. KEY ASSESSMENT QUESTIONS 1) What have you been told about this treatment plan with oral medications? * Verify that the patient knows that these oral agents are for cancer and are taken by mouth for their cancer. 2) What other medications or pills do you take by mouth? * If you have a list of medicines, go over the list with the patient. * If you do not have a list, ask the patient what medicines he/she is taking, (both prescription and non-prescription), herbs, complementary, or other treatments. 3) Are you able to swallow pills or tablets? If no, explain. 4) Are you able to read the drug label/information? 5) Are you able to open your other medicine bottles or packages? 6) Have you taken other pills for your cancer? * Find out if there were any problems, for example, taking the medications or any adverse drug effects. 7) Are you experiencing any symptoms that would affect your ability to keep down the pills, for example nausea or vomiting? 8) How will you fill your prescription? * Delays in obtaining the pills may affect when the oral drugs are started 9) Have you had any problems with your insurance that has interfered with obtaining your medications? Special Considerations when assessing patients receiving oral agents for cancer: When teaching the patient, you may need to adapt your teaching to accommodate special considerations such as, age, feeding tube, vision problems/color blindness, dietary issues, mental problems (dementia, depression, cognitive impairments). * Recommended information to assess is noted in italics PATIENT EDUCATION Generic Education for All Oral Drugs Discuss the following items with the patient and/or caretaker. 1) Inform any other doctors, dentists or healthcare providers that you are taking pills/tablets for your cancer. 2) Keep the pills/tablets away from children and pets and in a childproof container. 3) Keep the pills/tablets in the original container, unless otherwise directed. It could be dangerous to mix with other pills. 4) Wash your hands before and after handling the pills/tablets. 5) Do not crush, chew, cut or disrupt your pills/tablets unless directed otherwise 6) Store your pills/tablets away from heat, sunlight, or moisture as it may degrade the pills/tablets, potentially making them less effective. 7) Have a system to make sure you take your pills/tablets correctly. * Give the patient some ideas, such as timer, clock or calendar. 8) Make sure you have directions about what to do if you miss a dose 9) If you accidentally take too many pills or if someone else takes your pills/tablets, contact your Doctor or nurse immediately. 10) Ask your nurse or pharmacist what you should do with any pills/tablets you have not taken or are out-dated. * The patient may be asked to bring unused pills/tablets back to the next visit. 11) Carry with you a list of medicines that you are taking, including your cancer pills/tablets. 12) Let us know if you have a problem with paying for or getting your pills. 13) Plan ahead for travel, refills and weekends.
  • 15. MOATT © 2008 Multinational Association of Supportive Care in Cancer TM DRUG-SPECIFIC INFORMATION Drug name (generic and trade) __________________________________________ What the drug looks like __________________________________________ Dose and schedule How many different pills? __________________________________ How many times a day? ___________________________________ For how long? __________________________________________ Where the drug should be stored * Be specific, for example, away from heat (not in the kitchen), humidity (not in the bathroom), sun (not on the window sill) __________________________________________ __________________________________________ What are potential side effects and management of them? * Include lab evaluations or any medical tests that will be used for drug monitoring. __________________________________________ __________________________________________ __________________________________________ __________________________________________ Are there any precautions? __________________________________________ __________________________________________ __________________________________________ Are there any drug and food interactions? __________________________________________ __________________________________________ When and whom to call with questions * Give names and phone numbers here __________________________________________ __________________________________________ EVALUATE Have the patient and/or caregiver answer the following questions to ensure that they understand what information you have given them. You have received a lot of information today. Let’s review key points. What is/are the name(s) of your cancer pill(s)/tablet(s)? When will you take your cancer pill(s)/tablet(s)? Does it matter if you take this pill/tablet with food or not? Where do you plan to keep it? When should you call the Doctor or Nurse? Do you have any other questions? Your next appointment is? ______________________________________ For problems, contact ______________________________________ ______________________________________ ______________________________________ ______________________________________ ______________________________________ Drug-Specific Education – The following information relates to topics and references for the specific treatment that the patient is receiving. Refer to drug specific information to educate the patient on his/her pills/tablets References Product package insert or prescribing information http://www.cancerbackup.org.uk/Treatments/Ch emotherapy/Individualdrugs Micromedix AHFS Drug Info. http://www.cancersource.com/LibraryAndResou rces/DrugGuide/ http://www.naturaldatabase.com Add website addresses, email links, internet sites Whichever tool is used to educate the patient, include the following drug-specific information. You can complete the form provided below and give it to the patients using reference material you have on the specific pills/tablets. Drug name (generic and trade) What the drug looks like Dose and schedule. How many different pills? How many times a day? For how long? Where to store the drug * Be specific, for example, away from heat (not in the kitchen), humidity (not in the bathroom), sun (not on the window sill) What are potential side effects and management of them? * Include lab evaluations or any medical tests that will be used for drug monitoring. Are there any precautions? Are there any drug and food interactions? When and whom to call with questions * Give names and phone numbers here 9/14/2015 15
  • 16. Drug Diary One Oral Chemotherapy Once a Day DRUG NAME: Start Date:___________ How much:_________ How often:___________ When:___________ Your MD: ____________ Phone:____________ Your RN: ____________ Phone:____________ Special Instructions: Day Date Time Dose Symptoms Example 1/2/2011 9:30 AM 1 tablet upset stomach hour later 1 : AM/PM 2 : AM/PM 3 : AM/PM 4 : AM/PM 5 : AM/PM 9/14/2015 16
  • 17. Oral Chemo Videos • https://www.youtube.com/watch?v=vzVDafn3 iHA – 4-part, web based oral chemo animated video series – Available in English, Spanish, Portuguese, Mandarin, Russian, and Arabic 9/14/2015 17
  • 18. Conversation with Kitty Hooper • What is going on at DFCI now? – Initial phone call • MOATT • Pharmacy directed • Calls documented in EPIC – 72 hour adherence phone call • Program nurse • Go over side effects • Avg call 10-15 mins – 2 week follow-up visit with provider • 2 week peak drug toxicity • Review drug diaries – Every 2 months • May 2015: 80% of oral chemo pts had teaching Kitty Hooper, personal communication, August 11, 2015 9/14/2015 18
  • 19. Ongoing Issues at DFCI • Phone call based – No in person teaching • Initial education no longer done by nursing • Difficult to see if a patient is on oral chemotherapy • Lack of nursing knowledge • Inconsistencies in Research Nursing Kitty Hooper, August 2015 9/14/2015 19
  • 20. Suggestions for Improvement • Bring the education back to the nurses – Program nurse in each disease center – Oral Chemo Nurse position • Continue standardized documentation forms for telephone calls that include administration instructions, precautions, monitoring and managing SE, etc – Standardize Research oral chemo as well • Scheduling pt for 2 education appts w/RN prior to prescribing oral chemo • RN maintaining weekly call list for each patient on oral chemo • Routine follow-up phone calls or one week follow-up office visits • Improve view of oral chemo within EPIC • Providing classes for nurses & adding oral chemo as an annual competency (? Healthstream) 9/14/2015 20
  • 22. References Boucher, J., Lucca, J., Hooper, D., Pedulla, L., & Berry, D. (2015). A structured nursing intervention to address oral chemotherapy adherence in patients with non-small cell lung cancer. Oncology Nursing Forum, 42(4), 383-389. doi: 10.1188/15.ONF.383-389 Dana Farber Cancer Institute. (2015). Chemotherapy. Retrieved from http://www.dana-farber.org/Adult- Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Chemotherapy.aspx Moody, M., & Jackowski, J. (2014). Are patients on oral chemotherapy in your practice setting safe? Clinical Journal of Oncology Nursing, 14, 339–346. doi:10.1188/10.CJON.339-346 Nuess, M., Polovich, M., McNiff, K., Esper, P., Gilmore, T., LeFebvre, K., Schulmeister, L., & Jacobson, J. (2013). 2013 updated american society of clinical oncology/oncology nursing society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. Oncology Nursing Forum, 40(3), 225-233. doi:10.1188/13.ONF.40-03AP2 Penn Medicine. (2013). Patient adherence to oral cancer therapies: A nursing resource guide. OncoLink, 1-8. Retrieved from www.oncolink.org Rittenberg, C., Johnson, J., Kav, S., Barber, L., & Lemonde, M. (2010). MASCC oral agent teaching tool (MOATT). MASCC, 1-28. Roop, Janna & Wi, Horng-Shiuann. (2014). Current practice patterns for oral chemotherapy: Results of a national survey. Oncology Nursing Forum, 41(2), 185-194. doi:10.1188/14.ONF.41-02AP Wong, S., Bounthavong, M., Nguyen, C., Bechtoldt, K., & Hernandez, E. (2014). Implementation and preliminary outcomes of a comprehensive oral chemotherapy management clinic. American Journal of Health-System Pharmacy, 71(11) 960-965. doi: 10.2146/ajhp130278 9/14/2015 22
  • 23. 9/14/2015 23 DFCI, BWH, & Fred Flynn

Editor's Notes

  1. The most common ways to receive chemotherapy are through infusions or through pills you can take at home (oral chemotherapy) Oral chemotherapy is a cancer-fighting drug given by mouth in tablet, capsule, or liquid form. Just like any other form of chemotherapy, oral chemotherapy has the same benefits and risks. Today, many cancer patients receive oral chemotherapy as a treatment for their cancer. This method is sometimes easier than getting chemo by infusion at the hospital/clinic, because the medicine can be taken at home. Some patients report an increase in quality of life because of the less frequent hospital visits and because they feel they have control and management over their disease by taking it at home. However, it is important for patients to understand that these pills can be just as strong as the intravenous form of chemotherapy.
  2. How to take Swallow each tablet whole. Do not break/crush/chew Prepare drug away from food/food prep area If missed dose, tae as soon a possible. Almost time for next dose, skip missed dose and go back to regular dosing schedule DO NOT DOUBLE DOSE Clinical Trial– special instructions on how to take Informing healthcare team if you are unable to swallow pills If vomit up medication, call physician for special instructions Wash hands after taking med. Storage Most at tooom temperature, away from excess hear and moisture. Keep in original container, safe place away from other family medications. Away from reach of children and pets Disposal Unused chemo pills– return to pharmacy where prescription was filled. Don’t flush down toilet, dump in sink, throw in trash Body wastes Chemo stays in body for hours or even days and can be found in vomit, stool, urine, and sweat. Special care for accdiental contact with patient/ caregiver Use toilet as usual. Wash hands well with soap and water after using toilet. If body waste gets on body, wash with soap and water. Always wear gloves when cleaning equipment or disposing waste from urinal or commode Pregnant caregivers should not handle patient body waste Laundry Wear disposable gloves when handling sheets/clothes that have been soiled with bodily waste Wash these items separately from other laundry Education on side effects should be given to patient for the specific chemotherapy they are receiving A patients quality of life can be drastically decreased with increased side effects/poor management of side effects They should be educated and understand when to call the doctor if they notice any side effects and when it is necessary to come into the hospital to receive immediate care for potential side effects.
  3. Found out Pt was not correctly taking his medication and was missing doses Pt had been having side effects for weeks (skin changes) that the Pt had not informed any physician/nurse about. Thus was not treating side effects American Society of Clinical Oncology
  4. Socioeconomic Low language literacy Lack of family or social support Homelessness Lack of health insurance/medication Limited access to a pharmacy Busy work or social lifestyle Healthcare System Poor provider communication skills Poor patient-provider relationship Lack of knowledge on adherence Lack of reinforcement from healthcare provider Patient info materials written at a high literacy level Disease Asymptomatic Severity of symptoms Treatment Regimen Complex regimen Lack of quick benefit Side Effects Requires Significant behavioral chages Patient Related Physical factors Knowledge Deficit Attitiude, confidence, motivation Psychological/behavioral/developmental factors Perceived benefit of treatment Fear of possible adverse effects Stress/anxiety/anger Alcohol or Substance Abuse
  5. Side Effects are the most common reason that a patient would stop taking their oral chemotherapy. It is very important to educate the patient on the side effects of the medication and educate them on when to call the doctor. It is also important to follow up with the patients and ask them if they are having any side effects in order to manage and treat them early on. Targeted therapies– epidermal growth factor receptor inhibitors such as Erlotinib The most common body part affected by these drugs is the the skin. These include: an acne-like rash, drug skin, itching, nail changes, and hair changes. Although side effects are often mild or moderate, on occasion, they can be severe. When side effects are severe, the doctor may need to stop treatment either for a short time or permanently. So, it is important to know about preventing and treating the skin side effects. MASCC provides an educational sheet caled Caring for Your Skin Hair and Nails when on “Targeted Therapies” It provides education for the patients on what they should do to prevent or manage the side effects Example: Nail Changes Swelling/redness– wear soft shoes and avoid extreme heat or cold or bumping them MD might prescribe silver nitrate Pain/redness– soak fingers/toes in solution of white vinegar mixed in equal amount of tap water MD may prescribe antibiotic if an infection One Program Nurse, Kitty Hooper, emails her patients this educational sheet if they are on these specific targeted therapies
  6. The administration of chemotherapy drugs has shifted dramatically in the past 15 years from parenteral to oral administration Along with this change has come increased responsibility for pt self-management Thus the families bear the burden for the 5 rights of medication administrtion :pt, drug, dose, time, and route Family educationa nd follow-up are critical to treatment success with oral chemo Systematic reliable policies and procedures for pt education, documentation, and interdisciplinary communication are urgently needed reported less confidence in their ability to provide safe care because of their own knowledge deficits Respondents reinforced concerns that were uncovered in phase 1 of the study, stating that caring for patients taking oral chemotherapy is a “huge problem.” They noted that the support in place for IV chemotherapy is missing for patients on oral chemotherapy, and that no policies or systematic methods are available for providing teaching, routine follow-up, and regular assessment of their patients on oral chemotherapy Fragmentation of care and lack of consistent communication among healthcare providers Nursing Implication: nurses should provide education and repeated teaching to improve pt safety, adherence to the medication, and self-monitoring for adverse effects The American Society of Clinical Oncology and ONS have published and updated standards for chemotherapy administration safety. The 2013 standards were expanded to include oral chemotherapy. All editions of the standards assert that patients and families must receive extensive education about their chemotherapy before treatment begins
  7. Follow up Care- After the initial clinic visit, pts received follow-up care An OCM clinic with comprehensive medication therapy management services was effective in delivering early interventions, resulting in decreased adverse effects, non-adherence, drug interactions, and medication errors over time
  8. Objective Describe the development of an oral chemotherapy nursing position as well as role implementation in an ambulatory medical oncology setting Improve medication safety and adherence for patients taking oral chemo medications The oral chemo nursing role was initiated in August 2008. Since that time, she has cared for as many as 112 patients at one time. Initial teaching was provided for 163 patients. Nursing assessment and intervention were provided for 1710 patient visits prior to the start of the next cycle of chemo. Telephone triage was provided for 2410 patient calls. Since August 2008, three patients have altered from their prescribed doses of oral chemo during one cycle. Of those three cases, two were taught while oral chemo nurse was on vacation. With a nurse following pts taking oral chemo, pt safety has improved because pts understand how and when to take their chemo meds, when to report side effects, and comply with appts and meds. Pt documentation of side effects also has improved. Moody, M., & Jackowski, J. (2014). Are patients on oral chemotherapy in your practice setting safe? Clinical Journal of Oncology Nursing, 14, 339–346. doi:10.1188/10.CJON.339-346
  9. Donna Berry, Director of the Phyllis F. Cantor Center for Nursing Research She has another video further explaining this compliance issue and how it is so important that we educate these patients However it is hard to have the time because we used to have plenty of education time while we were hanging the chemotherapy. Now we don’t have as much time because these patients are just getting prescriptions. Thus it is so important that we have a systemized education system
  10. Multinational Association for Supportive Care in Cancer Oral Agent Teaching Tool (MOATT) Structured, nurse-led education sessions using the MAOTT were provided, with a 72-hour follow up telephone contact. Participants complete a Knowledge Rating Scale and adapted Morisky Medication Adherence Scale-8 at the end of the firsst cycle f oral chemotherapy Initial education provided oral and written materials Structured, nurse-led education and follow-up sessions ranged from 14-30 mins Scheduled clinic visit (2-3 weeks after starting therapy) or by phone 6-8 weeks reviewed the pts drug log Unplanned patient-initiated contact by phone was documented throughout the study The structure, nurse-led teaching, using the MOATT tool, and follow-up nurse contacts were feasible as integrated intot he thoracic oncolgy setting. The MOATT was feasible in regards to the time to adminiter educational session, which was lower than previous estimation of 60mmins from another study. Use of the MOATT in ambulatory cancer settings provides a valuable standardized education tool for assessemnt, generic and specifc medication education, and evaluation Patient self-management of oral chemotherapy also requires nurses’ support, using follow-up evaluation by telephone or during clinic visists after initial therapy starts Nurses role includes reinforcement of education (particularly in first 6-8 weeks) while monitoring for side effects that require support through symptom management using psyiological and psychosocial interventions.
  11. A drug diary can help patients to record daily medication use, keep track of special instructions and document side effects This tool can aide patients in taking their medications and keeping track of their side effects This also gives the patients a resource to use when following up with nurses & doctors
  12. DFCI is committed to educating pts and their families about the benefits and risks of oral chemo Since same safegaurds apply to oral chemo as do for infusions, DFCI created 4-part, web based oral chemo animated video series Includes: What is oral chemo Handling oral chemo safely at home Remembering to take oral chemo Managing symptoms and side effects of oral chemo
  13. Phone call based Patients aren’t physically seen until 2 weeks into treatment. From that point on, they are only seen every 2 months. It is very easy for side effects to go undetected and/or not treated This makes it easy for the pt to stop taking their chemo due to the side effects Pts could also be dealing with very dangerous side effects that are not being controlled because they did not call into the nurse/doctor to tell them It is easier to document and treat side effects with infusion chemotherapy as nurses get to spend the infusion time assessing the patient Different disease groups were having trouble finding someone to do the initial teaching phone call. Some departments had program nurses making the calls, but others weren’t able to do that. They now changed the policy so that pharmacists make the initial education phone call There is concern in this Pharmacy is very drug based where nursing is patient based. A huge part of nursing is educating and advocating for our patients, and by having pharmacy perform the initial teaching, the standard of education may not be the same as if it were done by a nurse. For patients that do come in for other treatments, such as concurrent chemo by infusion, it is hard for nurses to see that the patient is on oral chemo within Epic The fact that they are on oral chemo is often overlooked This could have been a perfect opportunity for reinforcement education, however, the nurse was not aware that the patient was on oral chemo There is an overall lack in nursing knowledge on the subject of oral chemotherapy. Many nurses do not have to give paitents oral chemotherapy, but when they do have to, many express that they have a lack of knowledge and need further education themselves to educate their patients Many nurses do not even know the educational resources on oral chemo that are available Asked 3 new nurses, none know about online resources/videos Research nurses have their own education protocols and educational information for their patients that is not the same as the standard education I believe that this information should be more standardized, and then further education regarding the research drug can be added on Supposed to be shown these resources at their new nurses orientation
  14. Education, assessment, and symptom management are all components of nursing and theses are all the crucial components that are needed for the safety and adherence of oral chemotherapy. Thus these components should be handled by nurses, not by the pharmacy This could either be done by having program nurses take on the responsibility or by creating a new oral chemo nurse position like the one in the research literature review Like I said previously, the base of oral chemo education should be standardized regardless if it is a research drug or not. Research nurses can then add their teaching and include the specific education that the protocol calls for Scheduling a pt for 2 education appts prior to prescribing the chemo allows for the pt to understand all of the content better and allows them more time to ask questions and receive clarification. In my own life, I am a very visual learner and would rather receive education in person rather than over the phone. I also like have the educational materials in front of me so that I can read along. The in person appts also gives the nurse the opportunity to show the pts the available online resources (videos, handouts, drug diaries) Weekly call list as well as routine phone calls or one week follow ups office visits, would make sure that no pts fall through the cracks and so that we are keeping track of how the pts treatment is going, documenting se, reinforcing educaiton, and treating any se Providing classes for nurses and adding an oral chemo competency would ensure that nurses are educated on oral chemo, are more competent in administering oral chemo, and are more confident in educating pts
  15. I owe a huge thank you to Mr. Flynn for allowing me the opportunity to take part in such an amazing experience here at Dana Farber. I have learned so many things in the last 8 weeks that will travel with me into my nursing career. So thank you Mr. Flynn.